Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.

Marder VJ, Comerota AJ, Shlansky-Goldberg RD, Davis JP, Deng C, Hanna K, Fineberg D.

J Thromb Haemost. 2012 Jun;10(6):985-91. doi: 10.1111/j.1538-7836.2012.04728.x.

2.

Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.

Skeik N, Gits CC, Ehrenwald E, Cragg AH.

Vasc Endovascular Surg. 2013 Oct;47(7):519-23. doi: 10.1177/1538574413497107.

PMID:
23899656
3.

Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO).

Han SM, Weaver FA, Comerota AJ, Perler BA, Joing M.

J Vasc Surg. 2010 Mar;51(3):600-9. doi: 10.1016/j.jvs.2009.08.053.

4.

Long-Term Outcomes of Catheter-Directed Thrombolysis for Acute Lower Extremity Occlusions of Native Arteries and Prosthetic Bypass Grafts.

Schrijver AM, de Vries JP, van den Heuvel DA, Moll FL.

Ann Vasc Surg. 2016 Feb;31:134-42. doi: 10.1016/j.avsg.2015.08.026.

PMID:
26627323
5.

Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.

Lee K, Istl A, Dubois L, DeRose G, Forbes TL, Wiseman D, Mujoomdar A, Kribs S, Power AH.

Vasc Endovascular Surg. 2015 Oct;49(7):175-9. doi: 10.1177/1538574415611234.

PMID:
26462979
6.

A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Shlansky-Goldberg RD, Matsumoto AH, Baumbach GA, Siegel JB, Raabe RD, Murphy TP, Deng C, Ray Dawkins J, Marder VJ.

J Thromb Haemost. 2008 Jun;6(6):944-50. doi: 10.1111/j.1538-7836.2008.02969.x.

7.

Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.

Raabe RD.

J Vasc Interv Radiol. 2010 Aug;21(8):1165-72. doi: 10.1016/j.jvir.2010.03.020.

PMID:
20656221
8.

Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.

Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR.

J Vasc Interv Radiol. 2003 Jun;14(6):729-33.

PMID:
12817039
9.

Independent factors predicting early lower limb intra-arterial thrombolysis failure.

Vakhitov D, Suominen V, Korhonen J, Oksala N, Salenius JP.

Ann Vasc Surg. 2014 Jan;28(1):164-9. doi: 10.1016/j.avsg.2012.11.016.

PMID:
24012090
10.

Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.

Wongwanit C, Hahtapornsawan S, Chinsakchai K, Sermsathanasawadi N, Hongku K, Ruangsetakit C, Mutirangura P.

J Med Assoc Thai. 2013 Jun;96(6):661-8.

PMID:
23951822
11.

Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.

Comerota AJ.

Thromb Res. 2008;122 Suppl 3:S20-6. doi: 10.1016/j.thromres.2008.06.012. Review.

PMID:
18701142
12.

Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infrainguinal disease (DUET): design and rationale.

Schrijver AM, Reijnen MM, van Oostayen JA, Nolthenius RP, van der Valk PH, Hoksbergen AW, Lely RJ, Fioole B, Vroegindeweij D, van Leersum M, de Vries JP.

Trials. 2011 Jan 23;12:20. doi: 10.1186/1745-6215-12-20.

13.

Catheter-directed thrombolysis with microplasmin for acute peripheral arterial occlusion (PAO): an exploratory study.

Verhamme P, Heye S, Peerlinck K, Cahillane G, Tangelder M, Fourneau I, Daenens K, Belmans A, Pakola S, Verhaeghe R, Maleux G.

Int Angiol. 2012 Jun;31(3):289-96.

PMID:
22634985
14.

Successful intra-arterial alteplase infusion is a predictor of 12-month limb survival in patients with lower limb arterial occlusion.

Disini L, Wilson P, Cockburn JF.

Clin Radiol. 2008 Jun;63(6):636-41. doi: 10.1016/j.crad.2007.10.017.

PMID:
18455554
15.

Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications.

Swischuk JL, Fox PF, Young K, Hussain S, Smouse B, Castañeda F, Brady TM.

J Vasc Interv Radiol. 2001 Apr;12(4):423-30.

PMID:
11287527
16.

Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.

Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B.

J Vasc Interv Radiol. 1999 Sep;10(8):1083-91.

PMID:
10496712
17.

Dethrombosis of lower extremity thrombus by local delivery of thrombolysis using ClearWay transcatheter balloon irrigation: a feasibility study.

Shammas NW, Weissman NJ, Coiner D, Shammas G, Jerin M, Christensen L.

Cardiovasc Revasc Med. 2011 Nov-Dec;12(6):350-4. doi: 10.1016/j.carrev.2011.06.002.

PMID:
21856248
18.
19.

Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.

Arepally A, Hofmann LV, Kim HS, Geschwind JF, Kirkwood S, Oechsle D, Perler B.

J Vasc Interv Radiol. 2002 Jan;13(1):45-50.

PMID:
11788694
20.

Low-dose thrombolysis for thromboembolic lower extremity arterial occlusions is effective without major hemorrhagic complications.

Ebben HP, Nederhoed JH, Lely RJ, Meijerink MR, van der Meijs BB, Wisselink W, Yeung KK, Hoksbergen AW.

Eur J Vasc Endovasc Surg. 2014 Nov;48(5):551-8. doi: 10.1016/j.ejvs.2014.06.042.

Items per page

Supplemental Content

Support Center